0000950170-24-072505.txt : 20240612
0000950170-24-072505.hdr.sgml : 20240612
20240612163538
ACCESSION NUMBER: 0000950170-24-072505
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240612
DATE AS OF CHANGE: 20240612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: REINHARDT MAX
CENTRAL INDEX KEY: 0001780058
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19961
FILM NUMBER: 241038873
MAIL ADDRESS:
STREET 1: C/O PACIRA BIOSCIENCES, INC.
STREET 2: 5401 WEST KENNEDY BOULEVARD, SUITE 890
CITY: TAMPA
STATE: FL
ZIP: 33609
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orthofix Medical Inc.
CENTRAL INDEX KEY: 0000884624
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
FISCAL YEAR END: 1223
BUSINESS ADDRESS:
STREET 1: 3451 PLANO PARKWAY
CITY: LEWISVILLE
STATE: TX
ZIP: 75056
BUSINESS PHONE: 214-937-2000
MAIL ADDRESS:
STREET 1: 3451 PLANO PARKWAY
CITY: LEWISVILLE
STATE: TX
ZIP: 75056
FORMER COMPANY:
FORMER CONFORMED NAME: ORTHOFIX INTERNATIONAL N V
DATE OF NAME CHANGE: 19970708
4
1
ownership.xml
4
X0508
4
2024-06-06
0000884624
Orthofix Medical Inc.
OFIX
0001780058
REINHARDT MAX
3451 PLANO PARKWAY
LEWISVILLE
TX
75056
false
true
false
false
President, Global Spine
false
Common Stock
2024-06-10
4
A
false
14401
13.02
A
14401
D
Employee Stock Option (Right to Buy)
13.02
2024-06-10
4
A
false
190731
0
A
2031-06-10
Common Stock
190731
190731
D
The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.
33,103 of the stock options vest upon achievement of both service- and performance-based criteria, whichever is the later of (a) the date certain service-based conditions are met (which will be met over three years) and (b) the date that the average closing price of the Company's common stock over a one-month calendar period has been equal to or great than 150% of the closing price of the Company's common stock on the grant date. The remaining 157,628 stock options vest on the third anniversary of the grant date.
/s/ J. Andres Cedron, attorney-in-fact
2024-06-12